chr21-46385908-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006031.6(PCNT):c.3389G>A(p.Arg1130Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. R1130R) has been classified as Benign.
Frequency
Consequence
NM_006031.6 missense
Scores
Clinical Significance
Conservation
Publications
- microcephalic osteodysplastic primordial dwarfism type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Moyamoya diseaseInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006031.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCNT | NM_006031.6 | MANE Select | c.3389G>A | p.Arg1130Gln | missense | Exon 17 of 47 | NP_006022.3 | ||
| PCNT | NM_001315529.2 | c.3035G>A | p.Arg1012Gln | missense | Exon 17 of 47 | NP_001302458.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PCNT | ENST00000359568.10 | TSL:1 MANE Select | c.3389G>A | p.Arg1130Gln | missense | Exon 17 of 47 | ENSP00000352572.5 | ||
| PCNT | ENST00000480896.5 | TSL:1 | c.3035G>A | p.Arg1012Gln | missense | Exon 17 of 47 | ENSP00000511989.1 | ||
| PCNT | ENST00000695558.1 | c.3389G>A | p.Arg1130Gln | missense | Exon 17 of 48 | ENSP00000512015.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152210Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251488 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461876Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74352 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
PCNT-related disorder Uncertain:1
The PCNT c.3389G>A variant is predicted to result in the amino acid substitution p.Arg1130Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.025% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at